SCHEMBL2404479

SCHEMBL2404479

CC1(C)CC(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL887697 0.86 APLNR (0.33)
SCHEMBL3627748 0.86 APLNR (0.39)
SCHEMBL13208978 0.77
SCHEMBL2497485 0.77
SCHEMBL1411809 0.76 APLNR (0.39)
SCHEMBL1411810 0.76 APLNR (0.39)
SCHEMBL1358179 0.76 APLNR (0.39)
SCHEMBL1358694 0.76 APLNR (0.39)
SCHEMBL15597234 0.76 APLNR (0.33)
SCHEMBL113337 0.76 APLNR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608664-B2 Curable sealant composition and method for manufacturing same BRIDGESTONE CORPORATION (JP) 2009-10-27 US claimed
US-7517936-B2 Curable sealant composition BRIDGESTONE CORPORATION (JP) 2009-04-14 US claimed
US-20080161491-A1 Curable Sealant Composition and Method for Manufacturing Same BRIDGESTONE CORPORATION (JP) 2008-07-03 US claimed
EP-1611166-B1 BUILDING SEALANT COMPOSITION BRIDGESTONE CORP (JP) 2007-08-29 EP claimed
US-20060217489-A1 Building sealant composition BRIDGESTONE CORPORATION (JP) 2006-09-28 US claimed
WO-2006078756-A1 CURABLE SEALANT COMPOSITION AND METHOD FOR MANUFACTURING SAME BRIDGESTONE CORPORATION (JP) 2006-07-27 WO claimed
EP-1611166-A2 BUILDING SEALANT COMPOSITION Bridgestone Corporation (JP) 2006-01-04 EP claimed
WO-2004090060-A2 BUILDING SEALANT COMPOSITION BRIDGESTONE CORPORATION (JP) 2004-10-21 WO claimed
US-6737470-B1 POLYCONJUGATED DIENE WITH TRIALKOXYSILANE TERMINAL GROUPS; LOW POLYDISPERSITY; LOW COST; SINGLE PACKAGE BRIDGESTONE CORPORATION (JP) 2004-05-18 US claimed
US-20260062412-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY CHUGAI PHARMACEUTICAL CO LTD (JP) 2026-03-05 US disclosed
US-20260035394-A1 1`-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF GILEAD SCIENCES INC (US) 2026-02-05 US disclosed
EP-4667477-A2 PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE Gilead Sciences, Inc. (US) 2025-12-24 EP disclosed
EP-4647424-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-11-12 EP disclosed
US-12448383-B2 Compounds and methods for treatment of viral infections GILEAD SCIENCES, INC. (US) 2025-10-21 US disclosed
US-20070161681-A1 ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES PFIZER INC. (US) 2007-07-12 US disclosed
EP-1790641-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-05-30 EP disclosed
US-7183293-B2 Ether derivatives useful as inhibitors of PDE4 isozymes PFIZER INC. (US) 2007-02-27 US disclosed
US-20060217489-A1 Building sealant composition BRIDGESTONE CORPORATION (JP) 2006-09-28 US disclosed
WO-2006078756-A1 CURABLE SEALANT COMPOSITION AND METHOD FOR MANUFACTURING SAME BRIDGESTONE CORPORATION (JP) 2006-07-27 WO disclosed
US-6737470-B1 POLYCONJUGATED DIENE WITH TRIALKOXYSILANE TERMINAL GROUPS; LOW POLYDISPERSITY; LOW COST; SINGLE PACKAGE BRIDGESTONE CORPORATION (JP) 2004-05-18 US disclosed